• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒与宫颈浸润前疾病

Human papilloma virus and cervical preinvasive disease.

作者信息

Peltecu Gheorghe, Bari Maria, Lancu George, Popa Florian

机构信息

Filantropia Hospital of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.

出版信息

J Med Life. 2009 Oct-Dec;2(4):373-7.

PMID:20108750
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3019010/
Abstract

Cervical cancer lesions represent a major threat to the health of the women worldwide. Human Papillomavirus (HPV) is responsible for 99.7% of cervical cancer cases, the infectious etiology giving the possibility of preventing cervical cancer by vaccination. The most aggressive HPV types are 16 and 18, which cause about 70% of cases of invasive cancer. The vaccination is recommended to the girls aged 11-12. The diagnosis and the treatment of cervical preinvasive disease allow the doctor to prevent the development of the invasive disease.

摘要

宫颈癌病变对全球女性健康构成重大威胁。人乳头瘤病毒(HPV)导致了99.7%的宫颈癌病例,这种感染病因使得通过接种疫苗预防宫颈癌成为可能。最具侵袭性的HPV类型是16型和18型,它们导致了约70%的浸润癌病例。建议11至12岁的女孩接种疫苗。宫颈浸润前疾病的诊断和治疗使医生能够预防浸润性疾病的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a84/3019010/749fc102294e/JMedLife-02-373-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a84/3019010/749fc102294e/JMedLife-02-373-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a84/3019010/749fc102294e/JMedLife-02-373-g001.jpg

相似文献

1
Human papilloma virus and cervical preinvasive disease.人乳头瘤病毒与宫颈浸润前疾病
J Med Life. 2009 Oct-Dec;2(4):373-7.
2
Human papillomavirus typing and the reduction of cervical cancer risk.人乳头瘤病毒分型与宫颈癌风险降低
Cleve Clin J Med. 1999 Oct;66(9):533-9. doi: 10.3949/ccjm.66.9.533.
3
Human papillomavirus vaccine as a new way of preventing cervical cancer: a dream or the future?人乳头瘤病毒疫苗作为预防宫颈癌的新方法:是梦想还是未来?
Ann Oncol. 2004 Feb;15(2):197-200. doi: 10.1093/annonc/mdh043.
4
Developments in L2-based human papillomavirus (HPV) vaccines.基于第二代的人乳头瘤病毒(HPV)疫苗的进展。
Virus Res. 2017 Mar 2;231:166-175. doi: 10.1016/j.virusres.2016.11.020. Epub 2016 Nov 23.
5
Prevention strategies of cervical cancer in the HPV vaccine era.人乳头瘤病毒疫苗时代的宫颈癌预防策略
Gynecol Oncol. 2006 Oct;103(1):21-4. doi: 10.1016/j.ygyno.2006.07.019. Epub 2006 Aug 17.
6
HPV vaccines.人乳头瘤病毒疫苗
Best Pract Res Clin Obstet Gynaecol. 2006 Apr;20(2):279-93. doi: 10.1016/j.bpobgyn.2005.10.011. Epub 2005 Dec 13.
7
[The role of human papillomavirus in carcinogenesis of cervical cancer and vaccination for HPV].[人乳头瘤病毒在宫颈癌致癌过程中的作用及人乳头瘤病毒疫苗]
Uirusu. 2002 Dec;52(2):287-93.
8
How will HPV vaccines affect cervical cancer?人乳头瘤病毒疫苗将如何影响宫颈癌?
Nat Rev Cancer. 2006 Oct;6(10):753-63. doi: 10.1038/nrc1973.
9
[Vaccination against human papillomavirus for the prevention of cervical cancer].[接种人乳头瘤病毒疫苗预防宫颈癌]
Ned Tijdschr Geneeskd. 2006 Jun 24;150(25):1380-4.
10
Cervical cancer, human papillomavirus, and vaccination.宫颈癌、人乳头瘤病毒与疫苗接种
BMJ. 2005 Oct 22;331(7522):915-6. doi: 10.1136/bmj.331.7522.915.

引用本文的文献

1
A case-control study based on the National Health and Nutrition Examination Survey to evaluate the effects of human papilloma virus on bone health in women.一项基于美国国家健康与营养检查调查的病例对照研究,旨在评估人乳头瘤病毒对女性骨骼健康的影响。
BMC Med. 2025 Feb 7;23(1):75. doi: 10.1186/s12916-025-03909-2.
2
Joint disease mapping of cervical and male oropharyngeal cancer incidence in blacks and whites in South Carolina.南卡罗来纳州黑人和白人中宫颈癌与男性口咽癌发病率的联合疾病图谱
Spat Spatiotemporal Epidemiol. 2010 Jul;1(2-3):133-41. doi: 10.1016/j.sste.2010.03.005.

本文引用的文献

1
HPV vaccines and cervical cancer.人乳头瘤病毒疫苗与宫颈癌
Ann Oncol. 2008 Jul;19 Suppl 5:v48-51. doi: 10.1093/annonc/mdn310.
2
Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis.持续性人乳头瘤病毒感染与宫颈肿瘤:一项系统评价与荟萃分析
Am J Epidemiol. 2008 Jul 15;168(2):123-37. doi: 10.1093/aje/kwn036. Epub 2008 May 15.
3
2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.2006年宫颈上皮内瘤变或原位腺癌女性管理共识指南
Am J Obstet Gynecol. 2007 Oct;197(4):340-5. doi: 10.1016/j.ajog.2007.07.050.
4
American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors.美国癌症协会关于使用人乳头瘤病毒(HPV)疫苗预防宫颈癌及其癌前病变的指南。
CA Cancer J Clin. 2007 Jan-Feb;57(1):7-28. doi: 10.3322/canjclin.57.1.7.
5
Prospects for cervical cancer prevention by human papillomavirus vaccination.人乳头瘤病毒疫苗预防宫颈癌的前景
Cancer Res. 2006 Nov 1;66(21):10229-32. doi: 10.1158/0008-5472.CAN-06-0630.
6
Using the new HPV vaccines in clinical practice.在临床实践中使用新型人乳头瘤病毒疫苗。
Cleve Clin J Med. 2006 Oct;73(10):929-35. doi: 10.3949/ccjm.73.10.929.
7
Vaccines against human papillomavirus and cervical cancer: promises and challenges.针对人乳头瘤病毒和宫颈癌的疫苗:前景与挑战
Oncologist. 2005 Aug;10(7):528-38. doi: 10.1634/theoncologist.10-7-528.
8
Treatment for cervical intraepithelial neoplasia and risk of preterm delivery.宫颈上皮内瘤变的治疗与早产风险
JAMA. 2004 May 5;291(17):2100-6. doi: 10.1001/jama.291.17.2100.
9
Attitudes about human papillomavirus vaccine in young women.年轻女性对人乳头瘤病毒疫苗的态度。
Int J STD AIDS. 2003 May;14(5):300-6. doi: 10.1258/095646203321605486.
10
The viral etiology of cervical cancer.宫颈癌的病毒病因学。
Virus Res. 2002 Nov;89(2):183-90. doi: 10.1016/s0168-1702(02)00187-9.